Want to see AU:BIO full AI Analyst Report?
BIO Stock Chart & Stats
AU$0.28
AU$0.02(5.88%)
At close: 4:00 PM EDT
AU$0.28
AU$0.02(5.88%)
Day’s Range― - ―
52-Week RangeAU$0.20 - AU$0.49
Previous CloseN/A
Volume215.99K
Average Volume (3M)154.15K
Market Cap
AU$83.31M
Enterprise ValueAU$59.75M
Total Cash (Recent Filing)AU$3.55M
Total Debt (Recent Filing)AU$2.97M
Price to Earnings (P/E)22.7
Beta1.08
Next Earnings
Feb 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding231,406,900
10 Day Avg. Volume129,896
30 Day Avg. Volume154,150
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)6.31
Price to Sales (P/S)2.48
P/FCF Ratio41.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.75Price Target Upside167.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.02
Revenue Forecast (FY)AU$33.00M
Bulls Say, Bears Say
Bulls Say
Rapid Revenue GrowthRevenue expansion of this magnitude indicates strong commercial traction and a growing customer base for the company’s probiotic products. A larger revenue base can improve operating leverage, support broader distribution, and provide a stronger platform for sustained growth over the coming quarters.
Profitability TurnaroundThe shift from multi-year losses to positive and increasing net income marks a meaningful improvement in the business model. If maintained, profitability should strengthen internal funding capacity, reduce reliance on external capital, and support continued investment in products and channels.
Positive Operating And Free Cash FlowPositive operating and free cash flow show that the recent earnings improvement is beginning to translate into cash generation. Sustained conversion would improve financial flexibility, help fund expansion internally, and provide greater capacity to manage debt while supporting future growth.
Bears Say
Unproven Cash-Flow DurabilityThe latest cash-flow improvement follows several years of negative operating and free cash flow, including a large outflow in 2025. This history makes the recent result less established, and continued volatility could constrain investment, debt reduction, and the company’s ability to self-fund growth.
Higher Debt BurdenDebt has risen alongside the company’s expansion, increasing the importance of maintaining profitability and cash generation. If earnings or cash flow weaken, servicing and managing this higher debt load could reduce financial flexibility and limit the funds available for strategic growth.
Volatile Operating ProfitabilityAlthough net income has improved, underlying operating profitability remains less consistent than revenue growth. Thin or negative operating results in recent periods suggest cost control and earnings quality still require improvement, creating uncertainty over how durable the reported profit uplift will be.
Biome Australia Ltd News
BIO FAQ
What was Biome Australia Ltd’s price range in the past 12 months?
Biome Australia Ltd lowest share price was AU$0.20 and its highest was AU$0.49 in the past 12 months.
What is Biome Australia Ltd’s market cap?
Biome Australia Ltd’s market cap is AU$83.31M.
When is Biome Australia Ltd’s upcoming earnings report date?
Biome Australia Ltd’s upcoming earnings report date is Feb 23, 2027 which is in 118 days.
How were Biome Australia Ltd’s earnings last quarter?
Biome Australia Ltd released its earnings results on Aug 25, 2026. The company reported AU$0.011 earnings per share for the quarter.
Is Biome Australia Ltd overvalued?
According to Wall Street analysts Biome Australia Ltd’s price is currently Undervalued.
Does Biome Australia Ltd pay dividends?
Biome Australia Ltd does not currently pay dividends.
What is Biome Australia Ltd’s EPS estimate?
Biome Australia Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biome Australia Ltd have?
Biome Australia Ltd has 231,406,900 shares outstanding.
What happened to Biome Australia Ltd’s price movement after its last earnings report?
Biome Australia Ltd reported an EPS of AU$0.011 in its last earnings report. Following the earnings report the stock price went up 7.692%.
Which hedge fund is a major shareholder of Biome Australia Ltd?
Currently, no hedge funds are holding shares in AU:BIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Biome Australia Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.75 (167.86% Upside)
AU$0.75 (167.86% Upside)
Blogger Sentiment
Bullish
AU:BIO Sentiment 100%
Sector Average 63%
Sector Average 63%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-23.40%
12-Months-Change
Fundamentals
Return on Equity
46.74%
Trailing 12-Months
Asset Growth
31.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Biome Australia Ltd
Biome Australia Limited, founded in 2018 and headquartered in Cremorne, Australia, specializes in the development, commercialization, and global distribution of live biotherapeutic and complementary health products. The company's product line features live biotherapeutics under the Activated Probiotics brand, organic nutritional supplements branded as Activated Nutrients, and athletic performance and recovery items named Activated X Performance. These offerings are accessible to consumers through both community pharmacies and independent health practitioners.
BIO Stock 12 Month Forecast
Average Price Target
AU$0.75
▲(167.86% Upside)
Technical Analysis
Immuron Limited
―
Avecho Biotechnology Limited
―
Anatara Lifesciences Ltd
―
Recce Pharmaceuticals Ltd.
―
Arovella Therapeutics Limited
―





